Hokkaido University Collection of Scholarly and Academic Papers >
Faculty of Pharmaceutical Sciences >
Peer-reviewed Journal Articles, etc >
A cross-sectional exploratory survey on occurrence of triple-whammy prescription pattern in Japan
Title: | A cross-sectional exploratory survey on occurrence of triple-whammy prescription pattern in Japan |
Authors: | Imai, Shungo Browse this author →KAKEN DB | Momo, Kenji Browse this author | Kashiwagi, Hitoshi Browse this author →KAKEN DB | Miyai, Takayuki Browse this author | Sugawara, Mitsuru Browse this author →KAKEN DB | Takekuma, Yoh Browse this author →KAKEN DB |
Keywords: | Acute kidney injury | Insurance claims | Japan | Triple-whammy prescriptions |
Issue Date: | 17-Aug-2020 |
Publisher: | Springer |
Journal Title: | International Journal of Clinical Pharmacy |
Volume: | 42 |
Start Page: | 1369 |
End Page: | 1373 |
Publisher DOI: | 10.1007/s11096-020-01088-z |
Abstract: | BackgroundThe concurrent use of nonsteroidal anti-inflammatory drugs, renin-angiotensin-aldosterone system blockers, and diuretics, known as a "triple-whammy," is related to the occurrence of acute kidney injury. However, there are few reports regarding the prescription pattern of the triple-whammy.ObjectiveTo elucidate the patterns of the triple-whammy prescription in Japan.MethodsA cross-sectional study was performed using a health-insurance-claims database that included Japanese people under 75 years of age, and enrolled outpatients that were prescribed any nonsteroidal anti-inflammatory drugs, renin-angiotensin-aldosterone system blockers, and diuretics between April 2017 and June 2017. As an outcome, the proportion of triple-whammy prescriptions was evaluated. Among the patients who received triple-whammy prescriptions, we evaluated the prevalence of chronic kidney disease and the proportion of prescriptions provided for these three drugs from different clinical departments and institutions.ResultsOverall, 730 of 246,721 (0.3%) patients received triple-whammy prescriptions. Among these patients, 13.3% had underlying chronic kidney disease. The proportions of any of the three drug types prescribed by different clinical departments and institutions was 48.2% and 61.8%, respectively.ConclusionsWe examined the patterns of triple-whammy prescriptions and concluded that pharmacists need to pay attention to triple-whammy prescriptions if the prescriptions are provided by multiple clinical departments or institutions. |
Rights: | This is a post-peer-review, pre-copyedit version of an article published in International Journal of Clinical Pharmacy. The final authenticated version is available online at: http://dx.doi.org/10.1007/s11096-020-01088-z. |
Type: | article (author version) |
URI: | http://hdl.handle.net/2115/82453 |
Appears in Collections: | 薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 今井 俊吾
|